Mycosis fungoides of the vulva

Mycosis fungoides (MF) is an indolent form of non-Hodgkin lymphoma and the most common type of primary cutaneous T-cell lymphoma. The overall incidence of MF is approximately 4 per 1 million. Involvement of the vulva by MF is extremely rare, with only seven reported cases in the literature. At the vulva, it is mainly a metastatic lesion and rarely a primary malignancy. We describe a case of vulvar MF and discuss the previous cases. The presentation can easily be confused with benign skin disorders. A vulvar lesion can reflect a systemic disease. When a patient consults for a vulvar lesion it is therefore important not only to look at the vulva but also to examine her in and ask general questions. In a patient with a vulvar mass and cuta-neous lesions on other locations MF should be considered in the differential diagnosis.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık

1. Tjalma WA, Van de Velde AL, Schroyens WA. Primary non-Hodgkin’s lymphoma in Bartholin’s gland. Gynecol Oncol 2002;87:308–9.
2. Bakar Ö, Şahin S, Çetinözman F, Willemze R, Tezcanli E, Çetin ED. Tumor-stage mycosis fungoides of the vulva successfully treated with local low-dose radiotherapy. Dermatol Ther 2015;28:36–9.
3. Reichman O, Sobel JD, Bentley G. Chronic vulvar fissure--a rare manifestation of mycosis fungoides. J Low Genit Tract Dis 2010;14:65–7.
4. Foss FM, Girardi M. Mycosis Fungoides and Sezary Syndrome. Hematol Oncol Clin North Am 2017;31:297–315.
5. Vang R, Medeiros LJ, Malpica A, Levenback C, Deavers M. Non-Hodgkin’s lymphoma involving the vulva. Int J Gynecol Pathol 2000;19: 236–42.
6. Buras AL, McSwain AN, Qin Y, Meunier JK. Primary mycosis fungoides of the vulva: The first reported case. Gynecol Oncol Rep 2015;12:7–8.
7. Geller S, Pitter K, Moskowitz A, Horwitz SM, Yahalom J, Myskowski PL. Treatment of Vulvar Mycosis Fungoides Tumors With Localized Radiotherapy. Clin Lymphoma Myeloma Leuk 2018;18:e279–81.
8. Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, et al; HAEMACARE Working Group. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010;116:3724–34.
9. Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 2007;143:854–9.
10. Galper SL, Smith BD, Wilson LD. Diagnosis and management of mycosis fungoides. Oncology (Williston Park) 2010;24:491–501.
11. Tjalma WA, Hauben EI, Deprez SM, Van Marck EA, van Dam PA. Epithelioid sarcoma of the vulva. Gynecol Oncol 1999;73:160–4.
12. Tjalma WA. Extramammary Paget’s disease of the vulva. J Am Coll Surg 2003;197:701–2.
13. Tjalma WA, Siozopoulou V, Huizing MT. A clitoral verrucous carcinoma in an area of lichen planus has aggressive features. World J Surg Oncol 2017;15:7.
14. Tjalma WA, Colpaert CG. Myxoid leiomyosarcoma of the vulva. Gynecol Oncol 2005;96:548–51.
15. Pimpinelli N, Olsen EA, Santucci M, Vonderheid E, Haeffner AC, Stevens S, et al; International Society for Cutaneous Lymphoma. Defining early mycosis fungoides. J Am Acad Dermatol 2005;53:1053–63.
16. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al; ISCL/EORTC. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007;110:1713–22.
17. Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, et al. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. J Clin Oncol 2015;33:3766–73.
18. Hoppe RT, Harrison C, Tavallaee M, Bashey S, Sundram U, Li S, et al. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials. J Am Acad Dermatol 2015;72:286–92.
19. Kim YH, Gratzinger D, Harrison C, Brody JD, Czerwinski DK, Ai WZ, et al. In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study. Blood 2012;119:355–63.
20. Kim YH, Tavallaee M, Sundram U, Salva KA, Wood GS, Li S, et al. Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project. J Clin Oncol 2015;33:3750–8.
21. Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 1996;132:1309–13.
22. Kim YH, Chow S, Varghese A, Hoppe RT. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol 1999;135:26–32.

APA	Tjalma W, Janssens M, Dam K, najim o, Van de Velde A, Huizing M, Berneman Z, schroyens w (2021). Mycosis fungoides of the vulva. , 101 - 105. 10.14744/nci.2020.12129
Chicago	Tjalma Wiebren AA,Janssens Michael,Dam Karen,najim omar,Van de Velde Ann,Huizing Manon,Berneman Zwi,schroyens wilfried Mycosis fungoides of the vulva. (2021): 101 - 105. 10.14744/nci.2020.12129
MLA	Tjalma Wiebren AA,Janssens Michael,Dam Karen,najim omar,Van de Velde Ann,Huizing Manon,Berneman Zwi,schroyens wilfried Mycosis fungoides of the vulva. , 2021, ss.101 - 105. 10.14744/nci.2020.12129
AMA	Tjalma W,Janssens M,Dam K,najim o,Van de Velde A,Huizing M,Berneman Z,schroyens w Mycosis fungoides of the vulva. . 2021; 101 - 105. 10.14744/nci.2020.12129
Vancouver	Tjalma W,Janssens M,Dam K,najim o,Van de Velde A,Huizing M,Berneman Z,schroyens w Mycosis fungoides of the vulva. . 2021; 101 - 105. 10.14744/nci.2020.12129
IEEE	Tjalma W,Janssens M,Dam K,najim o,Van de Velde A,Huizing M,Berneman Z,schroyens w "Mycosis fungoides of the vulva." , ss.101 - 105, 2021. 10.14744/nci.2020.12129
ISNAD	Tjalma, Wiebren AA vd. "Mycosis fungoides of the vulva". (2021), 101-105. https://doi.org/10.14744/nci.2020.12129

APA	Tjalma W, Janssens M, Dam K, najim o, Van de Velde A, Huizing M, Berneman Z, schroyens w (2021). Mycosis fungoides of the vulva. İstanbul Kuzey Klinikleri, 8(1), 101 - 105. 10.14744/nci.2020.12129
Chicago	Tjalma Wiebren AA,Janssens Michael,Dam Karen,najim omar,Van de Velde Ann,Huizing Manon,Berneman Zwi,schroyens wilfried Mycosis fungoides of the vulva. İstanbul Kuzey Klinikleri 8, no.1 (2021): 101 - 105. 10.14744/nci.2020.12129
MLA	Tjalma Wiebren AA,Janssens Michael,Dam Karen,najim omar,Van de Velde Ann,Huizing Manon,Berneman Zwi,schroyens wilfried Mycosis fungoides of the vulva. İstanbul Kuzey Klinikleri, vol.8, no.1, 2021, ss.101 - 105. 10.14744/nci.2020.12129
AMA	Tjalma W,Janssens M,Dam K,najim o,Van de Velde A,Huizing M,Berneman Z,schroyens w Mycosis fungoides of the vulva. İstanbul Kuzey Klinikleri. 2021; 8(1): 101 - 105. 10.14744/nci.2020.12129
Vancouver	Tjalma W,Janssens M,Dam K,najim o,Van de Velde A,Huizing M,Berneman Z,schroyens w Mycosis fungoides of the vulva. İstanbul Kuzey Klinikleri. 2021; 8(1): 101 - 105. 10.14744/nci.2020.12129
IEEE	Tjalma W,Janssens M,Dam K,najim o,Van de Velde A,Huizing M,Berneman Z,schroyens w "Mycosis fungoides of the vulva." İstanbul Kuzey Klinikleri, 8, ss.101 - 105, 2021. 10.14744/nci.2020.12129
ISNAD	Tjalma, Wiebren AA vd. "Mycosis fungoides of the vulva". İstanbul Kuzey Klinikleri 8/1 (2021), 101-105. https://doi.org/10.14744/nci.2020.12129